Poster: MDS-090: Phase II Study of the IDH2 Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS)

Authors :: Sangeetha Venugopal
Courtney D. DiNardo
Koichi Takahashi
Marina Konopleva
Sanam Loghavi
Gautam Borthakur
Amy DeZern
Lucia Masarova
Naval Daver
Nicholas J. Short
Yesid Alvarado
Farhad Ravandi
Guillermo Montalban-Bravo
Koji Sasaki
Ricardo Delumpa
Mikkael A. Sekeres
Bhumika Patel
Gail J. Roboz
Hagop M. Kantarjian
Guillermo Garcia-Manero
Source :: Clinical Lymphoma Myeloma and Leukemia. 21:S226
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Full Text Access

Tools